Trademark: 86263173
Word
SUTRO BIOPHARMA
Status
Dead
Status Code
710
Status Date
Friday, July 16, 2021
Serial Number
86263173
Registration Number
4652389
Registration Date
Tuesday, December 9, 2014
Mark Type
3000
Filing Date
Friday, April 25, 2014
Published for Opposition
Tuesday, September 23, 2014
Cancellation Date
Friday, July 16, 2021

Trademark Owner History
Sutro Biopharma, Inc. - Original Registrant

Classifications
5 Pharmaceutical preparations, namely, proteins and derivatives thereof for prophylactic, diagnostic, or therapeutic use in the nature of treating cancer, cardiovascular, hematopoietic, central nervous system, autoimmune, infectious, skin and skin structure, bone, genetic, endocrine or metabolic type diseases and ailments in humans and animals
40 Manufacture of pharmaceutical preparations for others
42 Research and development of pharmaceutical preparations for others
Color is not claimed as a feature of the mark.
"BIOPHARMA"
The mark consists of the words "SUTRO BIOPHARMA" in stylized font with an open circular design with ends above the "t" in "Sutro" and below the "u" in "Sutro" and four solid circles each larger than the next when viewed clockwise in the open circular design.

Trademark Events
Jul 16, 2021
Cancelled Sec. 8 (6-Yr)
Dec 9, 2019
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Dec 9, 2014
Registered-Principal Register
Sep 23, 2014
Official Gazette Publication Confirmation E-Mailed
Sep 23, 2014
Published For Opposition
Sep 3, 2014
Notification Of Notice Of Publication E-Mailed
Aug 18, 2014
Law Office Publication Review Completed
Aug 13, 2014
Approved For Pub - Principal Register
Aug 13, 2014
Examiner's Amendment Entered
Aug 13, 2014
Assigned To Lie
Aug 12, 2014
Notification Of Examiners Amendment E-Mailed
Aug 12, 2014
Examiners Amendment E-Mailed
Aug 12, 2014
Examiners Amendment -Written
Aug 7, 2014
Assigned To Examiner
May 10, 2014
Notice Of Design Search Code E-Mailed
May 9, 2014
New Application Office Supplied Data Entered In Tram
Apr 29, 2014
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24